1.
|
Balaiah V, Jeyaraman R and Chandrasekaran
L: Synthesis of 2,6-disubstituted piperidines, oxanes, and thianes.
Chem Rev. 83:3791983. View Article : Google Scholar
|
2.
|
Vijayakumar V and Sundaravadivelu M:
Synthesis and study on 2,4,6,8-tetraaryl-3,7-diazabicyclo[3.3.1].
Magn Reson Chem. 43:479–482. 2005.
|
3.
|
Juran S, Walther M, Stephan H, Bergmann R,
Steinbach J, Kraus W, Emmerling F and Comba P: Hexadentate
bispidine derivatives as versatile bifunctional chelate agents for
copper(II) radioisotopes. Bioconjug Chem. 20:347–359. 2009.
View Article : Google Scholar : PubMed/NCBI
|
4.
|
Joensuu H: Systemic chemotherapy for
cancer: from weapon to treatment. Lancet Oncol. 9:3042008.
View Article : Google Scholar : PubMed/NCBI
|
5.
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Ziegler DS and Kung AL: Therapeutic
targeting of apoptosis pathways in cancer. Curr Opin Oncol.
20:97–103. 2008. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Kurokawa M and Kornbluth S: Caspases and
kinases in a death grip. Cell. 138:838–854. 2009. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Desagher S and Martinou JC: Mitochondria
as the central control point of apoptosis. Trends Cell Biol.
10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Cory S and Adams JM: The Bcl-2 family:
regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
10.
|
Farrow NS and Brown R: New members of the
Bcl-2 family and their protein partners. Curr Opin Genet Develop.
6:45–49. 1996. View Article : Google Scholar : PubMed/NCBI
|
11.
|
Yang E, Zha J, Jockel J, Bosie LH,
Thompson CB and Korsmeyer SJ: Bad, a heterodimeric partner for
Bcl-xL and Bcl-2, displaces bax and promotes cell death. Cell.
80:285–291. 1995. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Verhagen AM, Ekert PG, Pakusch M, Silke J,
Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL:
Identification of DIABLO, a mammalian protein that promotes
apoptosis by binding to and antagonizing IAP proteins. Cell.
102:43–53. 2000. View Article : Google Scholar : PubMed/NCBI
|
14.
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar
|
15.
|
Kumar S and Vaux DL: Apoptosis. A
Cinderella caspase takes center stage. Science. 297:1290–1291.
2002. View Article : Google Scholar : PubMed/NCBI
|
16.
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163.
2005.PubMed/NCBI
|
17.
|
Liu J, Shen M, Yue Z, Yang Z, Wang M, Li
C, Xin C, Wang Y, Mei Q and Wang Z: Triptolide inhibits
colon-rectal cancer cells proliferation by induction of G1 phase
arrest through upregulation of p21. Phytomedicine. 19:756–762.
2012. View Article : Google Scholar : PubMed/NCBI
|
18.
|
Lodish H, Berk A, Zipursky SL, Matsudaria
P, Baltimore D and Darnell J: Molecular Cell Biology. 4th edition.
W.H. Freeman; New York, NY: 2000
|
19.
|
Zhao J, Kang SRM, Zhang X, You S, Park JS,
Jung JH and Kim DK: Apoptotic activity of a new jasmonate analogue
is associated with its induction of DNA damage. Oncol Rep.
24:771–777. 2010.PubMed/NCBI
|
20.
|
Fisher DE: Apoptosis in cancer therapy:
crossing the threshold. Cell. 78:539–542. 1994. View Article : Google Scholar : PubMed/NCBI
|
21.
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Tominaga H, Ishiyama M, Ohseto F, Sasamoto
K, Hamamoto T, Suzuki K and Watanabe M: A water-soluble tetrazolium
salt useful for colorimetric cell viability assay. Anal Commun.
36:47–50. 1999. View
Article : Google Scholar
|
23.
|
Zhang X, Zhao Z, Kang SRM, Yi MJ, You S,
Shin DS and Kim DK: A novel cromakalim analogue induces cell cycle
arrest and apoptosis in human cervical carcinoma HeLa cells through
the caspase- and mitochondria-dependent pathway. Int J Oncol.
39:1609–1617. 2011.
|
24.
|
Lin SY, Liu JD, Chang HC, Yeh SD, Lin CH
and Lee WS: Magnolol suppresses proliferation of cultured human
colon and liver cancer cells by inhibiting DNA synthesis and
activating apoptosis. J Cell Biochem. 84:532–544. 2002. View Article : Google Scholar : PubMed/NCBI
|
25.
|
Qi F, Li A, Zhao L, Xu H, Inagaki Y, Wang
D, Cui X, Gao B, Kokudo N, Nakata M and Tang W: Cinobufacini, an
aqueous extract from Bufo bufo gargarizans Cantor, induces
apoptosis through a mitochondria-mediated pathway in human
hepatocellular carcinoma cells. J Ethnopharmacol. 128:654–661.
2010.
|
26.
|
Zhang Y, Ahn EY, Jiang Y, Kim DK, Kang SG,
Wu C, Kang SW, Park JS, Son BW and Jung JH:
3-Chloro-2,5-dihydroxybenzyl alcohol activates human cervical
carcinoma HeLa cell apoptosis by inducing DNA damage. Int J Oncol.
31:1317–1323. 2007.PubMed/NCBI
|
27.
|
Sánchez I and Dynlacht BD: New insights
into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol.
16:311–321. 2005.PubMed/NCBI
|
28.
|
Lee S, Christakos S and Small MB:
Apoptosis and signal transduction: clues to a molecular mechanism.
Curr Opin Cell Biol. 5:286–291. 1993. View Article : Google Scholar : PubMed/NCBI
|
29.
|
Dou QP: Putative roles of retinoblastoma
protein in apoptosis. Apoptosis. 2:5–18. 1997.PubMed/NCBI
|
30.
|
Smith DM, Gao G, Zhang X, Wang G and Dou
QP: Regulation of tumor cell apoptotic sensitivity during the cell
cycle (Review). Int J Mol Med. 6:503–507. 2000.PubMed/NCBI
|
31.
|
Vermes I, Haanen C, Steffens-Nakken H and
Reutelingsperger C: A novel assay for apoptosis flow cytometric
detection of phosphatidylserine expression on early apoptotic cells
using fluorescein labelled Annexin V. J Immunol Methods. 184:39–51.
1995. View Article : Google Scholar
|
32.
|
Del Bino G, Darzynkiewicz Z, Degraef C,
Mosselmans R, Fokan D and Galand P: Comparison of methods based on
annexin-V binding, DNA content or TUNEL for evaluating cell death
in HL-60 and adherent MCF-7 cells. Cell Prolif. 32:25–37.
1999.PubMed/NCBI
|
33.
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
34.
|
Kiechle FL and Zhang X: Apoptosis:
biochemical aspects and clinical implications. Clin Chim Acta.
326:27–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
35.
|
Otsuki Y, Li Z and Shibata MA: Apoptotic
detection methods from morphology to gene. Prog Histochem Cytochem.
38:275–339. 2003. View Article : Google Scholar : PubMed/NCBI
|
36.
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
37.
|
Orren DK, Petersen LN and Bohr VA:
Persistent DNA damage inhibits S-phase and G2 progression and
results in apoptosis. Mol Biol Cell. 8:1129–1142. 1997. View Article : Google Scholar : PubMed/NCBI
|
38.
|
Qi F, Inagaki Y, Gao B, Cui X, Xu H,
Kokudo N, Li A and Tang W: Bufalin and cinobufagin induce apoptosis
of human hepatocellular carcinoma cells via Fas- and
mitochondria-mediated pathways. Cancer Sci. 102:951–958. 2011.
View Article : Google Scholar : PubMed/NCBI
|